Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas

Human Pathology

Volumn 35, Issue 5, 2004, Pages 546-551

  Carrilho, Carla ^b   Alberto, Matos ^b   Buane, Landim ^b   David, Leonor ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b NONE

Author keywords

Cervix cancer; Immunohistochemistry; Keratins; Tumor markers

Indexed keywords

KERATIN; KERATIN 10; KERATIN 13; KERATIN 17; KERATIN 8; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 2442672791     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.01.021     Document Type: Article

References (19)

1. Carrilho C, Cantel M, Gouveia P, et al: Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn, T and sialosyl-T) and gp 230 mucin-like glycoprotein are candidate markers for neoplastic transformation of the human cervix. Virchows Arch 437:173-179, 2000
2. Moll R, Franke WW, Schiller DL, et al: The catalogue of human cytokeratins: Patterns of expression in normal epithelial tumors and cultured cells. Cell 31:11-24, 1982
3. Moll R, Schiller DL, Franke WW: Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 111:567-580, 1990
4. Bobrow LG, Makin CA, Law S, et al: Expression of low molecular weight cytokeratin proteins in cervical neoplasia. J Pathol 148:135-140, 1986
5. Lane EB, Alexander CM: Use of keratin antibodies in tumor diagnosis. Semin Cancer Biol 1:165-179, 1990
6. Maddox P, Sasieni P, Szarewski A, et al: Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol 52:41-46, 1999
7. Smedts F, Ramaekers F, Robben H, et al: Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 136:657-668, 1990
8. Smedts F, Ramaekers F, Troyanovsky S, et al: Keratin expression in cervical cancer. Am J Pathol 141:497-511, 1992
9. Smedts F, Ramaekers F, Troyanovsky S, et al: Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol 140:601-612, 1992
10. Smedts F, Ramaekers F, Leube RE, et al: Expression of keratins 1, 6, 15, 16 and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia and in cervical carcinoma. Am J Pathol 142:403-412, 1993
11. Smedts F, Ramaekers F, Link M, et al: Detection of keratin subtypes in routinely processed cervical tissue: Implications for tumour classifications and the study of cervix cancer aetiology. Virchows Arch 425:145-155, 1994
12. Ivanyi D, Groeneveld E, van Doornewaard G, et al: Keratin subtypes in carcinomas of the uterine cervix: Implications for histogenesis and differential diagnosis. Cancer Res 50:5143-5152, 1990
13. Nair SA, Nair MB, Jayaprakash PG, et al: Cytokeratins and the evaluation of tumor differentiation in squamous lesions of the uterine cervix. Gen Diagn Pathol 143:15-22, 1997
14. Nair SA, Nair MB, Jayaprakash PG, et al: Increased expression of cytokeratins 14, 18 and 19 correlates with tumor progression in the uterine cervix. Pathobiology 65:100-107, 1997
15. Martens J, Baars J, Smedts F, et al: Can keratin 8 and 17 immunohistochemistry be of diagnostic value in cervical cytology? A feasibility study. Cancer 87:87-92, 1999
16. Raju GC: Expression of the cytokeratin marker CAM 5.2 in cervical neoplasia. Histopathology 12:437443, 1988
17. Scully RE, Bonfiglio TA, Kurman RJ, et al: Histological typing of the female genital tract tumors. Berlin, Springer Verlag, World Health Organization, 1994
18. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
19. van Bommel PF, Kenemans P, Helmerhorst TJ, et al: Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer 74:2314-2320, 1994